High-Dimensional SERS Mapping of Single Circulating Tumor Cells Deciphers the Phenotypic Landscape and Stratifies Metastatic Risk in Pancreatic Cancer
ACS Sensors · 2026
DOI: 10.1021/acssensors.6c01742 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sensors, 2026. Verfasst von Yanrong Wen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing210008, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neoplastic Cells, Circulating, Spectrum Analysis, Raman, Single-Cell Analysis. Die Arbeit nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Medical Science and technology development Foundation,Nanjing Department of Health.
Abstract (Originalsprache)
The profound phenotypic heterogeneity of circulating tumor cells (CTCs) presents a major analytical challenge, demanding technologies capable of high-plex, quantitative single-cell profiling. Here, we introduce PRISM (Phenotypic Resolution via Immuno-SERS Mapping), a biosensing platform engineered to meet this challenge. The platform integrates a high-efficiency dual-antibody (anti-EpCAM/anti-CSV) capture substrate with a suite of seven spectrally orthogonal SERS nanoprobes, enabling crosstalk-free, multiplexed quantification of epithelial, mesenchymal, and stem-like (E-M-S) markers. We demonstrate the platform's robust analytical performance, including high capture efficiency for heterogeneous cell lines and excellent linearity. Its superior phenotypic resolving power was validated by quantitatively distinguishing canonical cell line archetypes and tracking dynamic protein expression shifts during induced epithelial-mesenchymal transition. Applying PRISM to CTCs from pancreatic cancer patients, we introduce a novel data analysis framework, including a 'Metastasis Potential Score' (MPS), to translate high-dimensional spectral data into a clinically relevant metric for risk stratification. Furthermore, longitudinal analysis of patient samples demonstrates the platform's utility as a dynamic monitoring tool, capable of tracking therapy-induced phenotypic shifts. PRISM establishes a powerful analytical methodology for high-dimensional single-cell analysis, providing a robust tool for both fundamental cancer biology research and translational clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing210008, China.
- State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing211198, China.
- Physics and Chemistry Test Center of Jiangsu Province, Nanjing210042, China.
- Department of General Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing210008, China.
ORCID-Profile: Yanrong Wen, Huijun Li, Zuguo Zheng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Medical Science and technology development Foundation,Nanjing Department of Health
- Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University
Zitieren
APA
Wen, Y., Liu, M., Liu, C., Lin, F., Li, H., Cheng, H., He, J., & Zheng, Z. (2026). High-Dimensional SERS Mapping of Single Circulating Tumor Cells Deciphers the Phenotypic Landscape and Stratifies Metastatic Risk in Pancreatic Cancer. ACS Sensors. https://doi.org/10.1021/acssensors.6c01742
Vancouver
Wen Y, Liu M, Liu C, Lin F, Li H, Cheng H, et al. High-Dimensional SERS Mapping of Single Circulating Tumor Cells Deciphers the Phenotypic Landscape and Stratifies Metastatic Risk in Pancreatic Cancer. ACS Sensors. 2026. doi:10.1021/acssensors.6c01742
BibTeX
@article{Wen2026,
author = {Wen, Yanrong and Liu, Mengxiang and Liu, Chunhui and Lin, Fenxia and Li, Huijun and Cheng, Hao and He, Jian and Zheng, Zuguo},
title = {High-Dimensional SERS Mapping of Single Circulating Tumor Cells Deciphers the Phenotypic Landscape and Stratifies Metastatic Risk in Pancreatic Cancer},
journal = {ACS Sensors},
year = {2026},
doi = {10.1021/acssensors.6c01742}
}
EUVIMED